RT Journal Article
T1 Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol.
A1 Arévalos, Victor
A1 Ortega-Paz, Luis
A1 Fernandez-Rodríguez, Diego
A1 Alfonso Jiménez-Díaz, Víctor
A1 Rius, Jordi Bañeras
A1 Campo, Gianluca
A1 Rodríguez-Santamarta, Miguel
A1 de Prado, Armando Pérez
A1 Gómez-Menchero, Antonio
A1 Díaz Fernández, José Francisco
A1 Scardino, Claudia
A1 Gonzalo, Nieves
A1 Pernigotti, Alberto
A1 Alfonso, Fernando
A1 Jesús Amat-Santos, Ignacio
A1 Silvestro, Antonio
A1 Ielasi, Alfonso
A1 María de la Torre, José
A1 Bastidas, Gabriela
A1 Gómez-Lara, Josep
A1 Sabaté, Manel
A1 Brugaletta, Salvatore
A1 CV COVID-19 Registry Investigators, 
AB Patients presenting with the coronavirus-2019 disease (COVID-19) may have a high risk of cardiovascular adverse events, including death from cardiovascular causes. The long-term cardiovascular outcomes of these patients are entirely unknown. We aim to perform a registry of patients who have undergone a diagnostic nasopharyngeal swab for SARS-CoV-2 and to determine their long-term cardiovascular outcomes. This is a multicenter, observational, retrospective registry to be conducted at 17 centers in Spain and Italy (ClinicalTrials.gov number: NCT04359927). Consecutive patients older than 18 years, who underwent a real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for SARS-CoV2 in the participating institutions, will be included since March 2020, to August 2020. Patients will be classified into two groups, according to the results of the RT-PCR: COVID-19 positive or negative. The primary outcome will be cardiovascular mortality at 1 year. The secondary outcomes will be acute myocardial infarction, stroke, heart failure hospitalization, pulmonary embolism, and serious cardiac arrhythmias, at 1 year. Outcomes will be compared between the two groups. Events will be adjudicated by an independent clinical event committee. The results of this registry will contribute to a better understanding of the long-term cardiovascular implications of the COVID19.
YR 2021
FD 2021-07-29
LK http://hdl.handle.net/10668/18274
UL http://hdl.handle.net/10668/18274
LA en
DS RISalud
RD Apr 8, 2025